MSC-4106(Cat No.:I043431)is a selective small-molecule inhibitor targeting protein tyrosine phosphatase SHP2 (Src homology region 2-containing protein tyrosine phosphatase-2), a key regulator in the RAS/MAPK signaling pathway. SHP2 plays a crucial role in cell proliferation, differentiation, and survival, and its dysregulation is associated with various cancers and developmental disorders. By inhibiting SHP2, MSC-4106 blocks aberrant downstream signaling, offering potential for treating cancers driven by mutations in upstream receptors or RAS pathway components. MSC-4106 is also a valuable tool for exploring SHP2’s role in oncogenesis and immune regulation, supporting targeted cancer therapy development.